newcellsbiotech.co.uk Report : Visit Site

Technical data of the newcellsbiotech.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host newcellsbiotech.co.uk. Currently, hosted in United Kingdom and its service provider is Webfusion Internet Solutions .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.37 (Unix) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to content our expertise our offerings news & blog collaborate home we are transforming the drug discovery process your partner in the supply of human induced pluripotent stem cells and tissues what will you discover? the discovery of induced pluripotent stem cells in combination with advances in the understanding of human cell developmental biology has created the conditions for a revolution in pre-clinical science. newcells biotech is focused on using our proprietary technology to deliver the best biology into our assays products and services that give discovery and safety teams data that reduces risk and raises productivity in drug and chemical development. our approach delivers assays that are better models of human in vivo physiology for difficult to obtain cells and tissues. dr mike nicholds, chief executive officer our approach thinking new thinking human induced pluripotent stem cell (hipsc) lines are fast becoming key in advances in disease modelling, drug development and drug toxicity. by obtaining the "best in biology" human tissue samples and converting them into specific cell types, we can significantly improve the efficiency and predictability of early stage drug development. approaches new approaches using our hipsc and cell biology technology, we create differentiated cells and incorporate them into novel pre-clinical assays that provide pre-clinical data from human and other key species. opportunities new opportunities we have the expertise to collaborate with multidisciplinary teams in industry and academia. we are experts in developing cells of the retina, kidney, immune system and skin – making not just simple models, but complex miniature organs to mimic in vivo human physiology. discoveries new discoveries we can ethically source patient samples to produce quality controlled hipsc lines and incorporate these into in vitro models of diseases to accelerate exploration of targets and new chemical entities. our expertise we are experts in the production of hipsc lines and their differentiation. using our developed hipsc technology, we can collaborate with your drug discovery, development and toxicity teams to transform how you develop innovative drugs and compounds. our expertise in cell biology extends into the use of primary cells to produce innovative cross-species assays for transporter and toxicity studies. drug discovery a new drug can take on average 10 years from initial discovery stage to licensing approval, with each approved drug costing more than £1bn to develop, not to mention those that fail along the way. our cell based assay ipsc technology will transform your preclinical testing to reduce the unpredictable and costly nature of drug discovery. learn more in vitro safety and pharmacology predicting drug toxicity is still a challenge when developing safe pharmaceuticals and is a major contributor to the high cost of drug development. human derived ipscs opens new avenues for predictive in vitro models that reduce attrition rates and improve in vitro to in vivo translation. learn more do you have a question or query? get in touch we have the complete supply chain to develop, scale up and implement new in vitro assays for safety and efficacy testing. our focus is on cells and tissues which are difficult or impossible to source from primary sources and where we can produce better model of in vivo physiology to improve bench-to-human translation patient clinicians biobanks healthy disease patient sample acquisition service step 1 - healthy and disease patient sample acquisition service we work in partnership with an established ethically approved tissue supply company with a world-wide network of clinical contacts ipsc cell line derivation and quality control step 2 - ipsc cell line derivation and quality control we have protocols and teams that have produced over 1,800 quality controlled ipsc cell lines alongside our standard qc analysis we can provide a range of genetic analysis and disease mutation confirmation services assay development step 3 - assay development we work in partnership with drug discovery teams to develop novel disease modelling cell based assays drug safety and efficacy assessment step 4 - drug safety and efficacy assessment we have extensive experience of designing and implementing transporter and toxicity studies on behalf of customers. we are extending our capability to offer other toxicity and efficacy services based on primary and ipsc based assays. our offerings hipsc reprogramming we have the network and infrastructure to ethically source customer required samples, across a wide range of cell types from healthy and disease-affected individuals, and produce quality controlled hipsc lines ready for use in customers’ projects. assay products and services using primary or hipsc based platforms, we provide and are creating 24- to 96-well format cell based assays for customers to use in-house as well as a complementary service to design and conduct study protocols on behalf of customers’ teams. assay development our assay development teams collaborate to produce validated assays for disease modelling efficacy and safety studies for academic, pharmaceutical, cosmetic and chemical customers. collaborate with newcells biotech we are already collaborating on research projects with a wide range of partners, and welcome suggestions for new partnerships. we understand the complex interaction of multidisciplinary drug discovery and toxicology teams, which is why we offer a collaborative bespoke approach. if you have an enquiry about a potential collaboration, please contact us by clicking the button below. collaborate sign-up to our newsletter for the latest information about our work and projects. notice: javascript is required for this content. about newcells biotech management team news, blog & events careers contact us privacy policy terms of use biomedicine west international centre for life times square newcastle upon tyne ne1 4ep uk t: +44 (0)191 241 8695 © newcells biotech limited 2019 newcells biotech limited is registered in england, company number: 09389592

URL analysis for newcellsbiotech.co.uk

https://newcellsbiotech.co.uk/careers/
https://newcellsbiotech.co.uk/collaborate/
https://newcellsbiotech.co.uk/contact/
https://newcellsbiotech.co.uk/about-newcells/
https://newcellsbiotech.co.uk/#technology
https://newcellsbiotech.co.uk/#newstatements
https://newcellsbiotech.co.uk/about-newcells/#management
https://newcellsbiotech.co.uk/#content
https://newcellsbiotech.co.uk/in-vitro-safety-pharmacology/
https://newcellsbiotech.co.uk/#offerings
https://newcellsbiotech.co.uk/terms-of-use/
https://newcellsbiotech.co.uk/category/news,event,blog/
https://newcellsbiotech.co.uk/privacy-policy/
https://newcellsbiotech.co.uk/drug-discovery/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
newcellsbiotech.co.uk

Registrant:
CBSL Ltd

Registrant type:
UK Individual

Registrant's address:
Chairmans Office, International Centre for Life
Newcastle upon Tyne
Newcastle upon Tyne
NE1 4EP
United Kingdom

Data validation:
The registrar is responsible for having checked these contact details

Registrar:
123-Reg Limited t/a 123-reg [Tag = 123-REG]
URL: http://www.123-reg.co.uk

Relevant dates:
Registered on: 19-Jan-2015
Expiry date: 19-Jan-2019
Last updated: 12-Jan-2017

Registration status:
Registered until expiry date.

Name servers:
ns.123-reg.co.uk
ns2.123-reg.co.uk

WHOIS lookup made at 13:50:53 09-Jun-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS newcellsbiotech.co.uk

  PORT 43

  TYPE domain

OWNER

  ORGANIZATION CBSL Ltd

TYPE
UK Individual

ADDRESS
Chairmans Office, International Centre for Life
Newcastle upon Tyne
Newcastle upon Tyne
NE1 4EP
United Kingdom
Data validation:
The registrar is responsible for having checked these contact details

DOMAIN

  SPONSOR 123-Reg Limited t/a 123-reg [Tag = 123-REG]

  CREATED 2015-01-19

  CHANGED 2017-01-12

STATUS
Registered until expiry date.

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 92.51.159.40

  NAME newcellsbiotech.co.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .